Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
11.36
-0.07 (-0.61%)
Aug 12, 2025, 11:53 AM - Market open
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $1.50 billion as of August 12, 2025. Its market cap has increased by 86.70% in one year.
Market Cap
1.50B
Enterprise Value
1.26B
1-Year Change
86.70%
Ranking
Category
Stock Price
$11.36
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $1.50B, an increase of 1,091.48%. That is a compound annual growth rate of 25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 1.50B | 17.02% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |